Enveric Biosciences, Inc. (ENVB)

NCM – Real Time Price. Currency in USD

2.52

-0.29 (-10.32%)

At close: May 12, 2026, 4:00 PM EDT

05.05.2026

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today highlighted preclinical data for its lead candidate, EB-003, a dual 5-HT2A and 5-HT1B modulator, in which a single dose of EB-003 significantly reduced context-induced freezing behavior one hour post-dose (p < 0.05). These results indicate a rapid reduct.

28.04.2026

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq direct listing SARASOTA, Fla., April 28, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class, today announced the appointment of Joseph Tucker, Ph.D.

24.04.2026

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences, Inc (NASDAQ:ENVB) stock is trading higher on Friday after the U.S. Food and Drug Administration (FDA) accelerated action on psychedelics as treatments.

21.04.2026

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that Director and CEO, Joseph Tucker, Ph.D., will participate in a panel discussion at Needham's upcoming Virtual Psychedelics Forum. The panel, “Beyond TRD (Treatment-Resistant Depression): Non-Hallucinogens and New Indications,” is scheduled for.

20.04.2026

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Enveric surged more than 92% in premarket trading as investors rushed into psychedelic‑focused biotech names following the administration's weekend directive. The move sparked a sector‑wide rally.

20.04.2026

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Shares of psychedelic drug developers rose in premarket trading on Monday after U.S. President Donald Trump signed an executive order directing health regulators to speed up reviews of psychedelic drugs and boosted ‌federal research funding.

17.04.2026

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to.

Videos

No Data

There is no data to display

Press releases

05.05.2026

Enveric Biosciences, Inc. (ENVB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Videos

No Data

Press releases

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Videos

No Data

Press releases

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Search stocks

Enveric Biosciences, Inc. (ENVB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Videos

No Data

Press releases

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

What's Going On With Enveric Biosciences Stock On Friday?

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Psychedelic drug makers rally as Trump orders FDA to expedite reviews

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Videos

No Data

Press releases

Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum

Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules